| Dr Kevin Rene Grullon, MD | |
|
3535 W 13 Mile Rd Ste 507, Royal Oak, MI 48073-6770 | |
| (248) 551-0497 | |
| Not Available |
| Full Name | Dr Kevin Rene Grullon |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 24 Years |
| Location | 3535 W 13 Mile Rd Ste 507, Royal Oak, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295976645 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Fairview Southdale Hospital | Edina, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Minnesota Lung Center Ltd | 2860391521 | 12 |
| Northstar Sleep Center Llc | 7315104064 | 5 |
News Archive
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer's disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.
Abbott announced today that Abbott and AstraZeneca will discontinue their joint collaboration for the development of CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Henry Schein Cares, the global corporate social responsibility program of Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, is once again helping expand access to quality oral health care for underserved and at-risk populations through the Calendar of Caring Community Wellness Program.
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' survival might be to prevent the brain metastases from arising in the first place. With that in mind, researchers have been working on a predictive model that accurately identifies these high risk patients.
› Verified 9 days ago
| Entity Name | Minnesota Lung Center Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184655813 PECOS PAC ID: 2860391521 Enrollment ID: O20040102000187 |
News Archive
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer's disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.
Abbott announced today that Abbott and AstraZeneca will discontinue their joint collaboration for the development of CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Henry Schein Cares, the global corporate social responsibility program of Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, is once again helping expand access to quality oral health care for underserved and at-risk populations through the Calendar of Caring Community Wellness Program.
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' survival might be to prevent the brain metastases from arising in the first place. With that in mind, researchers have been working on a predictive model that accurately identifies these high risk patients.
› Verified 9 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer's disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.
Abbott announced today that Abbott and AstraZeneca will discontinue their joint collaboration for the development of CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Henry Schein Cares, the global corporate social responsibility program of Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, is once again helping expand access to quality oral health care for underserved and at-risk populations through the Calendar of Caring Community Wellness Program.
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' survival might be to prevent the brain metastases from arising in the first place. With that in mind, researchers have been working on a predictive model that accurately identifies these high risk patients.
› Verified 9 days ago
| Entity Name | Northstar Sleep Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124315700 PECOS PAC ID: 7315104064 Enrollment ID: O20120207000849 |
News Archive
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer's disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.
Abbott announced today that Abbott and AstraZeneca will discontinue their joint collaboration for the development of CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Henry Schein Cares, the global corporate social responsibility program of Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, is once again helping expand access to quality oral health care for underserved and at-risk populations through the Calendar of Caring Community Wellness Program.
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' survival might be to prevent the brain metastases from arising in the first place. With that in mind, researchers have been working on a predictive model that accurately identifies these high risk patients.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Rene Grullon, MD 3601 W 13 Mile 400 Fsc-pcs, Royal Oak, MI 48073-6769 Ph: (248) 423-2481 | Dr Kevin Rene Grullon, MD 3535 W 13 Mile Rd Ste 507, Royal Oak, MI 48073-6770 Ph: (248) 551-0497 |
News Archive
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer's disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.
Abbott announced today that Abbott and AstraZeneca will discontinue their joint collaboration for the development of CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Henry Schein Cares, the global corporate social responsibility program of Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, is once again helping expand access to quality oral health care for underserved and at-risk populations through the Calendar of Caring Community Wellness Program.
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' survival might be to prevent the brain metastases from arising in the first place. With that in mind, researchers have been working on a predictive model that accurately identifies these high risk patients.
› Verified 9 days ago
Nicole Marijanovich, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7999 Fax: 248-898-0580 | |
Vinayata Manuballa Kareti, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 661-948-0803 | |
Filip Ionescu, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3000 | |
Christopher Carpenter, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3535 W 13 Mile Rd Ste 605, Royal Oak, MI 48073 Phone: 248-551-0495 | |
Dr. Matthew Burns Cotant, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3577 W 13 Mile Rd, Suite 404, Royal Oak, MI 48073 Phone: 248-551-6900 Fax: 248-551-6909 | |
Geoffrey Prysak, MD, MPH Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7999 | |
Taylor Schoenheit, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6509 |